HSL inhibitors useful in the treatment of diabetes

Details for Australian Patent Application No. 2010294326 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Ackermann, Jean; Conte, Aurelia; Neidhart, Werner; Nettekoven, Matthias; Wertheimer, Stanley

Agent Spruson & Ferguson

Pub. Number AU-A-2010294326

PCT Pub. Number WO2011/029808

Priority 09170071.6 11.09.09 EP

Filing date 7 September 2010

Wipo publication date 17 March 2011

International Classifications

C07D 211/62 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/029808 Priority application(s): WO2011/029808

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010294331-Beverage machine in a network

2010294316-Composition and method for imaging stem cells